Position in MDXG
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$173,712
-$2,467,771 QoQ
Shares Held
45,120
-93.3% QoQ
Ownership
0.031%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#103
of 226 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MDXG Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026PRUDENTIAL FINANCIAL INC holds $557,787,882 across 190 Biotechnology names. MDXG ranks #130 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
130,659 | $81,471,112 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
133,294 | $66,211,127 | |
| 3 | BMRN |
Biomarin Pharmaceutical Inc
|
392,811 | $22,476,644 | |
| 4 | INCY |
Incyte Corp
|
191,312 | $21,687,128 | |
| 5 | CYTK |
Cytokinetics Inc
|
214,535 | $18,276,236 | |
| 6 | LGND |
Ligand Pharmaceuticals Inc
|
54,623 | $17,265,784 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
185,820 | $15,157,337 | |
| 8 | MRVI |
Maravai Lifesciences Holdings, Inc.
|
2,152,154 | $13,429,440 |
All Filings in MDXG
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $173,712 | 45,120 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $2,641,483 | 668,730 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,720,050 | 401,780 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $2,860,055 | 409,750 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $2,910,498 | 476,350 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $3,957,662 | 520,745 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $3,362,863 | 349,570 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,750,927 | 465,470 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $4,079,483 | 588,670 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $7,975,352 | 1,035,760 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $8,225,909 | 937,960 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $6,697,687 | 918,750 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $5,444,326 | 823,650 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $2,703,618 | 792,850 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,075,645 | 746,635 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,787,392 | 622,785 | Shares | Defined | 2022-11-04 | |
| 2022-06-30 | $940,664 | 271,085 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $628,243 | 133,385 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $707,797 | 117,185 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $66,781 | 11,020 | Shares | Defined | 2021-11-15 | |
| No filing history on record for this holder in this stock. | ||||||